(Q30373175)

21 June 2017

title

Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus. (English)

1 reference

21 June 2017

1 reference

1 reference

12

Chuan Qin

1 reference

21 June 2017

3

Linlin Bao

1 reference

21 June 2017

Zhe Chen

1

1 reference

21 June 2017

Jianmin Wang

2

1 reference

21 June 2017

Li Guo

4

1 reference

21 June 2017

Weijia Zhang

5

1 reference

21 June 2017

Ying Xue

6

1 reference

21 June 2017

Hongli Zhou

7

1 reference

21 June 2017

Yan Xiao

8

1 reference

21 June 2017

Jianwei Wang

9

1 reference

21 June 2017

Fan Wu

10

1 reference

21 June 2017

Ying Deng

11

1 reference

21 June 2017

Qi Jin

13

1 reference

21 June 2017

language of work or name

English

0 references

publication date

30 March 2015

1 reference

21 June 2017

published in

Nature Communications

1 reference

21 June 2017

volume

6

1 reference

21 June 2017

page(s)

6714

1 reference

Human infection with a novel avian-origin influenza A (H7N9) virus

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Clinical findings in 111 cases of influenza A (H7N9) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Influenza A (H7N9) and the importance of digital epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

A distinct lineage of influenza A virus from bats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

New world bats harbor diverse influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Update on avian influenza A (H5N1) virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Human infection with influenza H9N2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Antibodies for the prevention and treatment of viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Human monoclonal antibodies broadly neutralizing against influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

The mouse and ferret models for studying the novel avian-origin human influenza A (H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Epidemiology of human infections with avian influenza A(H7N9) virus in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Understanding influenza virus pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Receptor binding by an H7N9 influenza virus from humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Specific History of Heterologous Virus Infections Determines Anti-Viral Immunity and Immunopathology in the Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Anti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness

21 January 2018

1 reference

12 December 2020

Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.

1 reference

12 December 2020

A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

1 reference

12 December 2020

Integrin alpha(v)beta3 targeted therapy for Kaposi's sarcoma with an in vitro evolved antibody

1 reference

12 December 2020

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7714

7 January 2021

inferred from DOI database lookup

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

DOI

10.1038/NCOMMS7714

1 reference

Dimensions Publication ID

21 June 2017

0 references

1037813457

0 references

1 reference